Oscar Health (OSCR) Cash from Investing Activities (2020 - 2026)

Oscar Health's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$590.3 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 238.78% year-over-year to -$590.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$657.1 million (up 47.89% YoY) and the FY2025 annual result came in at -$241.1 million, up 82.63% from the prior year.
• Cash from Investing Activities was -$590.3 million for Q1 2026 at Oscar Health, down from -$48.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $298.8 million in Q3 2022 and bottomed at -$706.7 million in Q4 2022.
• A 5-year average of -$109.9 million and a median of -$31.4 million in 2024 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 2516.48% in 2022, while the deepest fall reached 3462.43% in 2022.
• Oscar Health's Cash from Investing Activities stood at -$706.7 million in 2022, then jumped by 124.41% to $172.5 million in 2023, then slumped by 118.23% to -$31.4 million in 2024, then plunged by 54.88% to -$48.7 million in 2025, then sank by 1111.87% to -$590.3 million in 2026.
• Business Quant data shows OSCR's Cash from Investing Activities at -$590.3 million in Q1 2026, -$48.7 million in Q4 2025, and $150.1 million in Q3 2025.